Bashan Drorinsider trades

In SEC Form 4 filings, Bashan Dror is listed as PRESIDENT AND CEO of Protalix BioTherapeutics, Inc. (PLX). Bashan Dror reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 4.

Companies and roles

Company	Role	Transactions	Last filed
PLXProtalix BioTherapeutics, Inc.	PRESIDENT AND CEO	2	Sep 4

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-04

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
PLXProtalix BioTherapeutics, Inc.	Sep 3	Sep 4	A · derivative	320,000	$2.59	$828,800	320,000	No	Form 4
PLXProtalix BioTherapeutics, Inc.	Sep 3	Sep 4	A · derivative	160,000	$0.00	$0	160,000	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.